Literature DB >> 27340322

Prescribing and borderline personality disorder.

Andrew M Chanen1, Katherine N Thompson2.   

Abstract

Accurate diagnosis is fundamental to effective management of borderline personality disorder, but many patients remain undetected. The first-line management for borderline personality disorder is psychosocial treatment, not drugs. There are major prescribing hazards including polypharmacy, overdose and misuse. Drug treatment might be warranted for patients who have a co-occurring mental disorder such as major depression. If a drug is prescribed for borderline personality disorder, it should only be as an adjunct to psychosocial treatment. There should be clear and collaborative goals that are regularly reviewed with the patient. Use single drugs prescribed in limited quantities for a limited time. Stop drugs that are ineffective.

Entities:  

Keywords:  anti-psychotic agent; antidepressant; borderline personality disorder; polypharmacy; psychosocial intervention strategy

Year:  2016        PMID: 27340322      PMCID: PMC4917638          DOI: 10.18773/austprescr.2016.019

Source DB:  PubMed          Journal:  Aust Prescr        ISSN: 0312-8008


  29 in total

1.  Family members' knowledge about borderline personality disorder: correspondence with their levels of depression, burden, distress, and expressed emotion.

Authors:  Perry D Hoffman; Ellie Buteau; Jill M Hooley; Alan E Fruzzetti; Martha L Bruce
Journal:  Fam Process       Date:  2003

2.  Suicide in borderline personality disorder: a meta-analysis.

Authors:  Maurizio Pompili; Paolo Girardi; Amedeo Ruberto; Roberto Tatarelli
Journal:  Nord J Psychiatry       Date:  2005       Impact factor: 2.202

3.  Epidemiology of personality disorders.

Authors:  Mark F Lenzenweger
Journal:  Psychiatr Clin North Am       Date:  2008-09

4.  Patient factors predicting early dropout from psychiatric outpatient care for borderline personality disorder.

Authors:  Chiara De Panfilis; Carlo Marchesi; Chiara Cabrino; Alberto Monici; Virginia Politi; Matteo Rossi; Carlo Maggini
Journal:  Psychiatry Res       Date:  2012-04-13       Impact factor: 3.222

5.  Treatment of personality disorder.

Authors:  Anthony W Bateman; John Gunderson; Roger Mulder
Journal:  Lancet       Date:  2015-02-20       Impact factor: 79.321

6.  Ten-year course of borderline personality disorder: psychopathology and function from the Collaborative Longitudinal Personality Disorders study.

Authors:  John G Gunderson; Robert L Stout; Thomas H McGlashan; M Tracie Shea; Leslie C Morey; Carlos M Grilo; Mary C Zanarini; Shirley Yen; John C Markowitz; Charles Sanislow; Emily Ansell; Anthony Pinto; Andrew E Skodol
Journal:  Arch Gen Psychiatry       Date:  2011-04-04

Review 7.  Pharmacological interventions for borderline personality disorder.

Authors:  Jutta Stoffers; Birgit A Völlm; Gerta Rücker; Antje Timmer; Nick Huband; Klaus Lieb
Journal:  Cochrane Database Syst Rev       Date:  2010-06-16

8.  Life expectancy at birth and all-cause mortality among people with personality disorder.

Authors:  Marcella Lei-Yee Fok; Richard D Hayes; Chin-Kuo Chang; Robert Stewart; Felicity J Callard; Paul Moran
Journal:  J Psychosom Res       Date:  2012-05-26       Impact factor: 3.006

9.  Revised NESARC personality disorder diagnoses: gender, prevalence, and comorbidity with substance dependence disorders.

Authors:  Timothy J Trull; Seungmin Jahng; Rachel L Tomko; Phillip K Wood; Kenneth J Sher
Journal:  J Pers Disord       Date:  2010-08

10.  Mental health service utilization by borderline personality disorder patients and Axis II comparison subjects followed prospectively for 6 years.

Authors:  Mary C Zanarini; Frances R Frankenburg; John Hennen; Kenneth R Silk
Journal:  J Clin Psychiatry       Date:  2004-01       Impact factor: 4.384

View more
  6 in total

1.  Prescribing and borderline personality disorder.

Authors:  Deirdre Criddle; Carolyne Wood
Journal:  Aust Prescr       Date:  2016-10-01

2.  A study comparing the experiences of family and friends of young people with borderline personality disorder features with family and friends of young people with other serious illnesses and general population adults.

Authors:  Mirra R Seigerman; Jennifer K Betts; Carol Hulbert; Ben McKechnie; Victoria K Rayner; Martina Jovev; Sue M Cotton; Louise McCutcheon; Catharine McNab; Emma Burke; Andrew M Chanen
Journal:  Borderline Personal Disord Emot Dysregul       Date:  2020-07-22

3.  Association between psychotropic prescriptions and the total amount of psychotropics ingested during an intentional overdose: A single-center retrospective study.

Authors:  Iori Tanahashi; Takafumi Shiganami; Takayuki Iwayama; Taisei Wake; Sayaka Kobayashi; Haruo Yoshimasu
Journal:  Neuropsychopharmacol Rep       Date:  2022-02-16

4.  Event-Related Potentials Altered in Patients with Borderline Personality Disorder during Working Memory Tasks.

Authors:  Ying Liu; Mingtian Zhong; Chang Xi; Xinhu Jin; Xiongzhao Zhu; Shuqiao Yao; Jinyao Yi
Journal:  Front Behav Neurosci       Date:  2017-04-18       Impact factor: 3.558

Review 5.  Borderline personality disorder in adolescents: prevalence, diagnosis, and treatment strategies.

Authors:  Jean Marc Guilé; Laure Boissel; Stéphanie Alaux-Cantin; Sébastien Garny de La Rivière
Journal:  Adolesc Health Med Ther       Date:  2018-11-23

6.  Unmet challenges in treating hypertension in patients with borderline personality disorder: A systematic review.

Authors:  Saara M Roininen; Marcus Cheetham; Beatrice U Mueller; Edouard Battegay
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.